How Immunotherapy Fights Leukemia, Lymphoma, and Multiple Myeloma

Over the last decade, scientists have made significant progress in using immunotherapy to improve outcomes for patients with blood cancers. Marco Ruella, MD, an Assistant Professor of Hematology-Oncology, explained one advance that his research is focusing on: “with the advent of gene editing, we are now able to modify our immunotherapies to make them more effective and potentially safer.”